C21 · Pharmaceuticals · United Kingdom
Newer medicines clawback rate
United Kingdom: 22.9% in 2025.
- 22.9% Latest · United Kingdom · 2025
- Annual Release cadence
- 1 Record · 1 region · 2025
Verified 17 Sep 2026 · 1 publisher · Next period 2026
The figure
One published observation so far. A chart follows as soon as a second period is published.
Newer medicines clawback rate
United Kingdom, 2025
Every record
1 record · 1 region · 2025. Each period links to its record: the value, its source evidence and original document.
Download this data
Every file carries its provenance: the CSV has a source column per row, and the chart images print the publisher, the licence and this page's address under the drawing. Source: ABPI. Licence: CC BY 4.0.
Use and publication rights
- View, cite and link: free
Quote any number, cite this page or a single record, and link to it anywhere.
- Copy, chart and republish: free with attribution
The data is published under CC BY 4.0, commercial use included. Credit StatOrigin and the original publisher (ABPI); the chart files already carry that line.
- The source documents: the publisher's terms
Figures are facts read from the publishers' own documents. The documents themselves, their text and design, stay under each publisher's terms; follow the source links for those.
How this measure is built
- Definition
- Effective revenue clawback rate applied to sales of newly marketed branded prescription medicines.
- Measure
- One slice of Sales clawback cap ( form: share, segment: newer medicines ) . Statutory or agreed ceiling on revenue clawback rates applied to pharmaceutical sales. Region and period are columns on every record, not slices.
- Limitations
- Values are shown as published; StatOrigin does not revise, fill gaps or convert currencies.
- Verification
- Each value, unit, period and place was checked against its source evidence before publication. See the methodology and the corrections process.
Sources · 1 document
| Document | Publisher | Published | Data points |
|---|---|---|---|
| Green shoots for UK pharma investment, but delivery will decide whether they take root | ABPI | — | 1 |
Other slices of sales clawback cap
- Branded medicines sales clawback cap 1 branded
Frequently asked questions
What is the latest newer medicines clawback rate?
United Kingdom: 22.9% in 2025.
Where does this data come from?
From 1 document published by ABPI. Every figure on this page links to its record, which preserves the original source evidence.
How often is it updated?
Annual. The newest published period is 2025; the next release should cover 2026. A new figure appears here once the publisher releases it and it passes verification.
Can I use this data?
Yes. StatOrigin publishes it under CC BY 4.0: you may copy, chart and republish it, including commercially, with attribution to StatOrigin and to the original publisher.
Cite this page
Cite the page as a data set, or open any record to cite one figure: each record carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.
StatOrigin. (2026). Newer medicines clawback rate [Data set]. Retrieved October 28, 2026, from https://statorigin.org/indicators/newer-medicines-clawback-rate
"Newer medicines clawback rate." StatOrigin, 2026, https://statorigin.org/indicators/newer-medicines-clawback-rate. Accessed 28 Oct. 2026.
StatOrigin. "Newer medicines clawback rate." Data set, 2026. Accessed October 28, 2026. https://statorigin.org/indicators/newer-medicines-clawback-rate.
@misc{statorigin_newer_medicines_clawback_rate_2026, title = {Newer medicines clawback rate}, author = {{StatOrigin}}, year = {2026}, url = {https://statorigin.org/indicators/newer-medicines-clawback-rate}, note = {Data set. Accessed 2026-10-28} }